With the government trying to cut down costs on health spending, market access for oncology therapeutics is becoming more complicated and difficult. On the other hand, oncology medications, which are usually considered to be especially innovative, are increasing in demand.
To ensure a better and faster way of collaboration between industry, regulation and payers and help meet the ultimate goal – patient access to innovative medications, Fleming Europe has decided to include a brand new stream on Oncology market access to its 8th Annual Pricing, Reimbursement & Market Access In Pharma conference.
Taking place on 17 – 18 January 2013 in Barcelona, this conference will promote a wide range of presentations, practical case studies, interactive sessions and debates by bringing together 80 – 120 senior experts from the field of pricing, reimbursement and market access.
The stream A will bring the focus on breaking issues and strategic insights into pricing and reimbursement, the power of patients, smoother access from regional perspectives, innovations in healthcare and the role of HTAs.
Top pharma companies will share their experiences and the attendees will have a unique opportunity to hear about their best practices and their impact on the market:
How is the AMNOG shaping up? • The power of patients • Risk-sharing success stories in the UK • Drug assessment in France one year after the new legislative context • Budget cuts in Italy - How does the market react? • The role of HTA in Spain
Topics covering oncology market access, will be presented and discussed in the framework of the stream B. 6 presentations, 6 case studies and 3 interactive discussions will reveal the future drivers in oncology in order to customize the product value story and compete for premium reimbursement:
Integrated market access strategies • Homecare programs in oncology • Utilization of risk-sharing schemes • Reimbursement challenges for personalized medicine • OECD project on pharmaceutical value-based pricing
Come to Barcelona and meet Senior Vice Presidents, Vice Presidents, Senior Executives, Heads, Directors, Managers, Advisors, Strategists and Analysts of Pharmaceutical companies responsible for Pricing, Reimbursement, Market Access, HTA Policy, Government Affairs and extend your stock of information and valuable advice from qualified experts.
If you want to be up-to-date with the latest developments in the areas of pricing, reimbursement and market access, join our Pharma Market Access Forum.
About Fleming Europe
Established in Slovakia, Fleming Europe represents a Pan-European B2B networking channel for specialists to collect & share knowledge. Since 2004, the company has been encouraging decision makers in sharing their experiences through market leading conferences, trainings and webinars. The annual audience of 10,000 Banking, Defense, Energy, Oil & Gas, Pharma, Telco and Transport peers benefit from insights on industry trends when applying them to their own business practices. For more information visit www.flemingeurope.com
To ensure a better and faster way of collaboration between industry, regulation and payers and help meet the ultimate goal – patient access to innovative medications, Fleming Europe has decided to include a brand new stream on Oncology market access to its 8th Annual Pricing, Reimbursement & Market Access In Pharma conference.
Taking place on 17 – 18 January 2013 in Barcelona, this conference will promote a wide range of presentations, practical case studies, interactive sessions and debates by bringing together 80 – 120 senior experts from the field of pricing, reimbursement and market access.
The stream A will bring the focus on breaking issues and strategic insights into pricing and reimbursement, the power of patients, smoother access from regional perspectives, innovations in healthcare and the role of HTAs.
Top pharma companies will share their experiences and the attendees will have a unique opportunity to hear about their best practices and their impact on the market:
How is the AMNOG shaping up? • The power of patients • Risk-sharing success stories in the UK • Drug assessment in France one year after the new legislative context • Budget cuts in Italy - How does the market react? • The role of HTA in Spain
Topics covering oncology market access, will be presented and discussed in the framework of the stream B. 6 presentations, 6 case studies and 3 interactive discussions will reveal the future drivers in oncology in order to customize the product value story and compete for premium reimbursement:
Integrated market access strategies • Homecare programs in oncology • Utilization of risk-sharing schemes • Reimbursement challenges for personalized medicine • OECD project on pharmaceutical value-based pricing
Come to Barcelona and meet Senior Vice Presidents, Vice Presidents, Senior Executives, Heads, Directors, Managers, Advisors, Strategists and Analysts of Pharmaceutical companies responsible for Pricing, Reimbursement, Market Access, HTA Policy, Government Affairs and extend your stock of information and valuable advice from qualified experts.
If you want to be up-to-date with the latest developments in the areas of pricing, reimbursement and market access, join our Pharma Market Access Forum.
About Fleming Europe
Established in Slovakia, Fleming Europe represents a Pan-European B2B networking channel for specialists to collect & share knowledge. Since 2004, the company has been encouraging decision makers in sharing their experiences through market leading conferences, trainings and webinars. The annual audience of 10,000 Banking, Defense, Energy, Oil & Gas, Pharma, Telco and Transport peers benefit from insights on industry trends when applying them to their own business practices. For more information visit www.flemingeurope.com
